A policy change that kept more teenagers in school for an additional year has offered researchers an unusual way to examine the long-term relationship between education and dementia. The findings suggest a small reduction in later-life diagnoses among people affected by the reform, with the strongest signal among those carrying greater genetic risk.

The study is important because it uses a “natural experiment”: a change in law rather than a voluntary choice by participants. That design can reduce some of the bias that affects ordinary observational research. It does not, however, prove that one extra year of school will prevent dementia for any individual.

What changed in the United Kingdom

In 1972, the minimum school-leaving age in the United Kingdom rose from 15 to 16. The reform increased the proportion of teenagers who stayed in school to age 16 by about 14 percentage points. Researchers later compared health outcomes for people born just before and just after the eligibility cutoff, using information from more than 100,000 UK Biobank participants.

Over roughly five decades, the additional year of compulsory schooling was associated with a 0.88 percentage-point reduction in diagnoses of Alzheimer’s disease and related dementias. Overall diagnosis rates in the cohort were low, so this is best understood as a modest population-level difference rather than a dramatic protective effect.

Why a natural experiment matters

People who remain in education longer often differ from those who leave earlier in income, family circumstances, health, employment and access to care. Those differences can make it difficult to tell whether education itself matters. A sudden legal cutoff creates two groups that are more comparable because the extra schooling was imposed by policy, not selected solely by personal preference.

Even this design has limits. A school reform may influence many things at once: qualifications, occupational options, income, health literacy, social networks and use of healthcare. The study cannot isolate a single biological pathway that explains the association.

The genetic-risk finding needs careful interpretation

The reduction in diagnoses appeared strongest among participants with higher inherited susceptibility to dementia. That observation raises a useful research question: education and the opportunities that follow it may help build cognitive reserve or alter life-course exposures in ways that are especially relevant for people at elevated risk.

It should not be read as a genetic test result or a guarantee. Genetic risk scores are research tools, and dementia develops through a complex interaction of age, genes, cardiovascular health, lifestyle, environment and social conditions.

What this does not mean

The study does not show that returning to school in midlife will reduce an individual’s dementia risk by a specific amount. It does not replace established advice on controlling blood pressure, staying physically active, avoiding smoking, addressing hearing loss, sleeping adequately and seeking medical assessment for concerning symptoms.

The participants included in the analysis were no older than 65 at the time of the reported follow-up. Because dementia becomes much more common at older ages, the size and certainty of the association may change as the cohort ages. Diagnosis records may also miss people who have symptoms but have not received a formal diagnosis.

A public-health signal, not a personal prescription

The most useful interpretation is structural. Education policy can have health consequences that extend far beyond the classroom, and benefits or harms may emerge decades later. The result supports continued investigation into how learning, opportunity and socioeconomic conditions across the life course shape brain health.

For individuals, dementia prevention remains probabilistic rather than absolute. No single educational choice can eliminate risk. For policymakers, however, the study adds to evidence that investment in education may deliver long-term health returns that conventional short-term evaluations overlook.

Source: National Institutes of Health, October 23, 2026.